Cargando…

P glycoprotein (P-gp) and drug resistance--time for reappraisal?

Detalles Bibliográficos
Autor principal:	Kaye, S. B.
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 1993
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1968337/ https://www.ncbi.nlm.nih.gov/pubmed/8097103

Ejemplares similares

Effect of P-glycoprotein (P-gp) Inducers on Exposure of P-gp Substrates: Review of Clinical Drug–Drug Interaction Studies
por: Elmeliegy, Mohamed, et al.
Publicado: (2020)

The equilibrium and kinetic drug binding properties of the mouse P-gp1a and P-gp1b P-glycoproteins are similar
por: Taylor, J C, et al.
Publicado: (1999)

Natural Products as Alternative Choices for P-Glycoprotein (P-gp) Inhibition
por: Dewanjee, Saikat, et al.
Publicado: (2017)

Hypoxia-induced drug resistance: comparison to P-glycoprotein-associated drug resistance.
por: Sakata, K., et al.
Publicado: (1991)

Selective modulation of P-glycoprotein-mediated drug resistance
por: Bebawy, M, et al.
Publicado: (2001)

Chemical biology fluorescent tools for in vitro investigation of the multidrug resistant P-glycoprotein (P-gp) expression in tumor cells
por: Daumar, Pierre, et al.
Publicado: (2023)

Convulsive Stress Mimics Brain Hypoxia and Promotes the P-Glycoprotein (P-gp) and Erythropoietin Receptor Overexpression. Recombinant Human Erythropoietin Effect on P-gp Activity
por: Merelli, Amalia, et al.
Publicado: (2019)

P-Glycoprotein and Drug Resistance in Systemic Autoimmune Diseases
por: Picchianti-Diamanti, Andrea, et al.
Publicado: (2014)

Dual P-Glycoprotein and CA XII Inhibitors: A New Strategy to Reverse the P-gp Mediated Multidrug Resistance (MDR) in Cancer Cells †
por: Teodori, Elisabetta, et al.
Publicado: (2020)

No evidence for interactions of dimethylfumarate (DMF) and its main metabolite monomethylfumarate (MMF) with human cytochrome P450 (CYP) enzymes and the P‐glycoprotein (P‐gp) drug transporter
por: Aubets, Jordi, et al.
Publicado: (2019)

Acquired Drug Resistance Enhances Imidazoquinoline Efflux by P-Glycoprotein
por: Pulukuri, Anunay J., et al.
Publicado: (2021)

Characterization of P-Glycoprotein Inhibitors for Evaluating the Effect of P-Glycoprotein on the Intestinal Absorption of Drugs
por: Kono, Yusuke, et al.
Publicado: (2021)

Ecdysteroid Derivatives that Reverse P-Glycoprotein-Mediated Drug Resistance
por: Bortolozzi, Roberta, et al.
Publicado: (2020)

ERBB and P‐glycoprotein inhibitors break resistance in relapsed neuroblastoma models through P‐glycoprotein
por: Rösch, Lisa, et al.
Publicado: (2022)

Salmonella Overcomes Drug Resistance in Tumor through P-glycoprotein Downregulation
por: Yang, Chih-Jen, et al.
Publicado: (2018)

Resistance to cancer chemotherapy: failure in drug response from ADME to P-gp
por: Alfarouk, Khalid O, et al.
Publicado: (2015)

Probing the Allosteric Modulation of P-Glycoprotein: A Medicinal Chemistry Approach Toward the Identification of Noncompetitive P-Gp Inhibitors
por: Bonito, Cátia A., et al.
Publicado: (2023)

Abraxane, the Nanoparticle Formulation of Paclitaxel Can Induce Drug Resistance by Up-Regulation of P-gp
por: Zhao, Minzhi, et al.
Publicado: (2015)

Bioinformatic analysis of highly consumed phytochemicals as P-gp binders to overcome drug-resistance
por: Rajaei, Narges, et al.
Publicado: (2023)

P-glycoprotein transporter in drug development
por: Prachayasittikul, Veda, et al.
Publicado: (2016)

New Dual P-Glycoprotein (P-gp) and Human Carbonic Anhydrase XII (hCA XII) Inhibitors as Multidrug Resistance (MDR) Reversers in Cancer Cells
por: Braconi, Laura, et al.
Publicado: (2022)

Interaction of tamoxifen with the multidrug resistance P-glycoprotein.
por: Callaghan, R., et al.
Publicado: (1995)

P-gp and taxanes
por: Hendrikx, Jeroen J.M.A., et al.
Publicado: (2014)

Development of Classification Models for Identifying “True” P-glycoprotein (P-gp) Inhibitors Through Inhibition, ATPase Activation and Monolayer Efflux Assays
por: Rapposelli, Simona, et al.
Publicado: (2012)

Malaria in pregnancy regulates P‐glycoprotein (P‐gp/Abcb1a) and ABCA1 efflux transporters in the Mouse Visceral Yolk Sac
por: Martinelli, Lilian M., et al.
Publicado: (2020)

Targeting P-glycoprotein: Investigation of piperine analogs for overcoming drug resistance in cancer
por: Syed, Safiulla Basha, et al.
Publicado: (2017)

Esters of the Marine-Derived Triterpene Sipholenol A Reverse P-GP-Mediated Drug Resistance
por: Zhang, Yongchao, et al.
Publicado: (2015)

Subtle Structural Differences Trigger Inhibitory Activity of Propafenone Analogues at the Two Polyspecific ABC Transporters: P‐Glycoprotein (P‐gp) and Breast Cancer Resistance Protein (BCRP)
por: Schwarz, Theresa, et al.
Publicado: (2016)

Uncoupling GP1 and GP2 expression in the Lassa virus glycoprotein complex: implications for GP1 ectodomain shedding
por: Illick, Megan M, et al.
Publicado: (2008)

A unique antigenic epitope of human melanoma is carried on the common melanoma glycoprotein gp95/p97
Publicado: (1989)

Glycan shield of the ebolavirus envelope glycoprotein GP
por: Peng, Weiwei, et al.
Publicado: (2022)

LightSpot(®)-FL-1 Fluorescent Probe: An Innovative Tool for Cancer Drug Resistance Analysis by Direct Detection and Quantification of the P-glycoprotein (P-gp) on Monolayer Culture and Spheroid Triple Negative Breast Cancer Models
por: Goisnard, Antoine, et al.
Publicado: (2021)

P‐Glycoprotein (P‐gp)/ABCB1 plays a functional role in extravillous trophoblast (EVT) invasion and is decreased in the pre‐eclamptic placenta
por: Dunk, Caroline E., et al.
Publicado: (2018)

P-glycoprotein Inhibition for Optimal Drug Delivery
por: Amin, Md. Lutful
Publicado: (2013)

P-glycoprotein and metallothionein expression and resistance to chemotherapy in osteosarcoma.
por: Shnyder, S. D., et al.
Publicado: (1998)

Expression and cellular trafficking of GP82 and GP90 glycoproteins during Trypanosoma cruzi metacyclogenesis
por: Bayer-Santos, Ethel, et al.
Publicado: (2013)

Editorial: FDA-Approved Drug Repositioning for P-Glycoprotein Overexpressing Resistant Cancer
por: Yoon, Sungpil, et al.
Publicado: (2021)

Study Models of Drug–Drug Interactions Involving P-Glycoprotein: The Potential Benefit of P-Glycoprotein Modulation at the Kidney and Intestinal Levels
por: Veiga-Matos, Jéssica, et al.
Publicado: (2023)

Carbon nano-onion-mediated dual targeting of P-selectin and P-glycoprotein to overcome cancer drug resistance
por: Wang, Hai, et al.
Publicado: (2021)

Predicting P-Glycoprotein-Mediated Drug Transport Based On Support Vector Machine and Three-Dimensional Crystal Structure of P-glycoprotein
por: Bikadi, Zsolt, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_cro92gbfh3uhf79n2mujdvn7cq